Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 172

Results For "Eni"

2257 News Found

AbbVie and Allergan Aesthetics to present new research at 2022 AAD annual meeting
Biotech | March 22, 2022

AbbVie and Allergan Aesthetics to present new research at 2022 AAD annual meeting

Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications


Thermo Fisher Scientific to showcase global innovation at DCAT Week 2022
Medical Device | March 22, 2022

Thermo Fisher Scientific to showcase global innovation at DCAT Week 2022

Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers


NIBIOHN identifies tissue-specific exosome marker candidates from blood
Biotech | March 22, 2022

NIBIOHN identifies tissue-specific exosome marker candidates from blood

Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease


Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
Biotech | March 22, 2022

Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine

Data published in the prestigious journal ACS Central Science of the American Chemical Society


Mandaviya launches BRICS vaccine R&D centre
Policy | March 22, 2022

Mandaviya launches BRICS vaccine R&D centre

The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines


Biological Dynamics study demonstrates detection of early-stage cancers
Biotech | March 21, 2022

Biological Dynamics study demonstrates detection of early-stage cancers

In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis


physIQ and CellCarta collaborate to personalise vaccine development
Biotech | March 21, 2022

physIQ and CellCarta collaborate to personalise vaccine development

Moving well beyond the traditional approach of testing a vaccine’s collective response in large populations, this precision approach can identify how an individual’s own immune system responds to a vaccine, offering an unprecedented opportunity to measure vaccine safety and effectiveness


Mylab to open new facility in Vishakhapatnam
News | March 21, 2022

Mylab to open new facility in Vishakhapatnam

Spread over 43,000 square feet, the facility will be set up to cater to the increasing demand for transformative molecular testing in India and across the world for early and accurate diagnosis


Hetero gets CDSCO approval to manufacture and sell Sputnik Light in India
News | March 21, 2022

Hetero gets CDSCO approval to manufacture and sell Sputnik Light in India

Sputnik Light is the first component of Sputnik V


Merck discontinues KEYLYNK-101 trial to treat prostate cancer
Biotech | March 18, 2022

Merck discontinues KEYLYNK-101 trial to treat prostate cancer

At the interim analysis, the combination of Keytruda and Lynparza did not demonstrate a benefit in overall survival (OS), one of the study’s dual primary endpoints, compared to the control arm of either abiraterone acetate or enzalutamide